Douglas C. Bryant - 01 Feb 2024 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Feb 2024, 20:10:17 UTC
Prior SEC filing
02 Feb 2024
Next SEC filing
12 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip S. Askim, attorney-in-fact for Douglas C. Bryant

Key filing fact

Douglas C. Bryant filed Form 4 for QuidelOrtho Corp (QDEL) on 05 Feb 2024.

Key facts

  • This page summarizes Douglas C. Bryant's Form 4 filing for QuidelOrtho Corp (QDEL).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Feb 2024, 20:10.

Change

  • Previous filing in this sequence was filed on 02 Feb 2024.
  • Current net transaction value: -$170,795.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Award

Transaction value
$0
Shares
+1,116
Change %
+0.2%
Price
$0.000000
Shares after
548,110
Date
01 Feb 2024
Ownership
Direct
Footnotes
F1
QDEL transaction

Common Stock

Tax liability

Transaction value
$39,309
Shares
-566
Change %
-0.1%
Price
$69.45
Shares after
547,544
Date
01 Feb 2024
Ownership
Direct
Footnotes
F2
QDEL transaction

Common Stock

Award

Transaction value
$0
Shares
+3,795
Change %
+0.69%
Price
$0.000000
Shares after
551,339
Date
03 Feb 2024
Ownership
Direct
Footnotes
F1
QDEL transaction

Common Stock

Tax liability

Transaction value
$131,486
Shares
-1,924
Change %
-0.35%
Price
$68.34
Shares after
549,415
Date
03 Feb 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,116
Change %
-50%
Price
$0.000000
Shares after
1,116
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,116
Exercise price
Footnotes
F3, F4
QDEL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-3,795
Change %
-100%
Price
$0.000000*
Shares after
0
Date
03 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,795
Exercise price
Footnotes
F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Reflects release of restricted stock units that were previously reported on a Form 4.

Footnote F2

Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

Footnote F3

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F4

1,116 shares vested on February 1, 2024; the remaining 1,116 shares will vest on February 1, 2025.

Footnote F5

3,795 shares vested on February 3, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .